IFS Cloud 25R2: Unlocking 10X Industrial Workforce Capacity with Digital Workers and Applied Industrial AI

IFS Cloud 25R2: Unlocking 10X Industrial Workforce Capacity with Digital Workers and Applied Industrial AI

Latest release demonstrates how IFS.ai continues to deliver contextual, embedded, industry-specific intelligence, and now agentic Digital Workers, to drive measurable outcomes, at speed, in the mission-critical industries that keep our world...

RheoFit Closes Pre-A Led by Xiaohongshu (RED) and ZhenFund

RheoFit Closes Pre-A Led by Xiaohongshu (RED) and ZhenFund

SHENZHEN, China, Nov. 27, 2025 /PRNewswire/ -- On October 24, RheoFit, a consumer electronics company specializing in musculoskeletal health, announced the completion of its Pre-A funding round, led by Xiaohongshu (RED) and ZhenFund. The company...

Minesto AB: Interim Management Statement 1 January - 30 September 2025

Minesto AB: Interim Management Statement 1 January - 30 September 2025

GOTHENBURG, Sweden and VÄSTRA GÖTALAND, Sweden, Nov. 27, 2025 /PRNewswire/ -- CEO Dr Martin Edlund:"Minesto moves forward with a funded and reinforced action plan for commercial breakthrough." Significant events July-September 2025 In July Minesto...

Lenovo Neptune Powers the World's Greenest and Most Efficient HPC & AI Systems, Delivering up to 40% Lower Energy Use

Lenovo Neptune Powers the World's Greenest and Most Efficient HPC & AI Systems, Delivering up to 40% Lower Energy Use

Lenovo ranks #1 on the Top500 Supercomputers and Green500 lists Neptune systems deliver up to 100% heat removal achieving 1.1 PUE Warm-water cooling operates up to ~45 °C, eliminating chilled-water requirements SYDNEY, Nov. 27, 2025 /PRNewswire/ --...

Once-Monthly GLP-1 RA | Gan & Lee Pharmaceuticals Initiates Phase 3 Clinical Study (GRADUAL-3) of the First Chinese Once-Monthly GLP-1 RA for Weight Management

Once-Monthly GLP-1 RA | Gan & Lee Pharmaceuticals Initiates Phase 3 Clinical Study (GRADUAL-3) of the First Chinese Once-Monthly GLP-1 RA for Weight Management

BEIJING, Nov. 27, 2025 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, stock code: 603087.SH) announced the initiation of GRADUAL-3, its third large-scale phase 3 clinical study of the glucagon-like peptide-1 receptor agonist (GLP-1...

FUKU.AI Unveils Fiona: The AI Interviewer Built for High-Volume Hiring in Asian SMEs

FUKU.AI Unveils Fiona: The AI Interviewer Built for High-Volume Hiring in Asian SMEs

SINGAPORE, Nov. 27, 2025 /PRNewswire/ -- Hiring at Asia's fast-growing SMEs just got a turbo boost. FUKU.AI, the Singapore-headquartered startup building agentic recruitment tools for SMEs across Asia, today announced the general availability of...

MOIN Expands Strategic Partnership with Nium, Enhancing Global Remittance and Settlement Services

MOIN Expands Strategic Partnership with Nium, Enhancing Global Remittance and Settlement Services

SEOUL, South Korea, Nov. 27, 2025 /PRNewswire/ -- MOIN, a leading fintech company specializing in cross-border payment solutions, announced the expansion of its strategic partnership with Nium, the global infrastructure for real-time payments, at...

Hong Leong Finance Enters Fast-Growing Punggol District, Reimagines Customer Experience with Digital Innovations

Hong Leong Finance Enters Fast-Growing Punggol District, Reimagines Customer Experience with Digital Innovations

Officially opens its next-generation new branch at Punggol Coast Mall to tap a high-growth residential and commercial area Introduces digital LED art wall and use of augmented reality to engage customers Launch of revamped website to improve user...

GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology

GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology

YONGIN, South Korea, Nov. 27, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its collaborative study with Professor Byeon, Jeong-Sik's team at Asan Medical Center has been published in The...

SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation

SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation

New addition strengthens SK Biopharmaceuticals' radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partnerships and value chain integration SEOUL, South Korea, Nov. 27, 2025 /PRNewswire/ -- SK...

  • 1
  • ...
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • ...
  • 202
  • menu
    menu